Immunogenicity 14795
Sample ID
3903
Response
Negative
Tumor Type
Melanoma
Gene Symbol
FMN2
Transcript ID
uc010pyf.1
HLA INFO
B*38:01
TCR INFO
No TCR info found!
Full length protein sequence (251 aa)
MVVKL
1
LSNKR
6
SQAVG
11
ILMSS
16
LHLDM
21
KDIQH
26
AVVNL
31
DNSVV
36
DLETL
41
QALYE
46
NRAQS
51
DELEK
56
IEKHG
61
RSSKD
66
KENAK
71
SLDKP
76
EQFLY
81
ELSLI
86
PNFSE
91
RVFCI
96
LFQST
101
FSESI
106
CSIRR
111
KLELL
116
QKLCE
121
TLKNG
126
PGVMQ
131
VLGLV
136
LAFGN
141
YMNGG
146
NKTRG
151
QADGF
156
GLDIL
161
PKLKD
166
VKSSD
171
NSRSL
176
LSYIV
181
SYYLR
186
NFDED
191
AGKEQ
196
CLFPL
201
PEPQD
206
LFQAS
211
QMKFE
216
DFQKD
221
LRKLK
226
KDLKA
231
KIDQE
236
AEENS
241
LTETH
246
K
251
Mutation Information
DNA mutation:
None
Peptide Range:
51 ~ 75
Mut AA position:
None (None in Wild Type peptide)
Alignment
Wild Type:
"NRAQSDELEKIEKHGRSSKDKENAK
||||||||||||.||||||||||||
Mutant:
NRAQSDELEKIEQHGRSSKDKENAK"
Nat Med, 2016
Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patientsGene Name (from Reference) FMN2
Checkpoint
Blockade
None
ACT
None
Vaccination
None
Curative
Effect
None
minimal_peptide
None
Antigen
Type
TMG RNA
T-cell
Source
PBMCs
APC
Type
autologous DCs
Assay
IFNg ELISPOT assay